The Future of eClinical Trial Solutions - Market Forecasts to 2015, Competitive Benchmarking and Case Studies
GBI Research12 / 2009
|Regionen:||Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika|
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
GBI Research, the leading business intelligence provider, has released its latest research, 'The Future of e-Clinical Trial Solutions - Market Forecasts to 2015, Competitive Benchmarking and Case Studies which provides key data and analysis of the major factors affecting the market for e-Clinical trial solutions in the pharmaceuticals industry. The report also analyzes the strengths, weaknesses, opportunities and threats in the e-Clinical trial solutions market and the key market drivers and barriers to the adoption of e-Clinical trial solutions in the industry.
The report is based on proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts.
The scope of this report includes:
- Detailed market characterization including market size and technology adoption, and forecasts until 2015.
- Data and analysis on the e-clinical trial solutions market in the leading geographies of the world — the US, Europe and Asia Pacific.
- Analysis and review of the key events and milestones that will impact the future of the global e-clinical trial solutions market. Each trend is independently researched to provide qualitative analysis of its implications.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the global e-clinical trial solutions market in the long run.
- Case Studies on cost cutting in clinical trials for clinical trial management systems, clinical supply chain management systems, clinical data management systems, intellectual voice response systems, e-diaries and standardization.
- The report also covers information on the leading market players and the competitive landscape. Key companies covered include Oracle Corporation, SAS, Clinplus, Phase Forward, Perceptive Informatics and Omnicomm systems.
Reasons to buy
The report will enhance your decision making capability and will allow you to:
- Develop business strategies by understanding the trends shaping and driving the e-clinical trial solutions market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the e-clinical trial solutions market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the e-clinical trial solutions market landscape? — Identify, understand and capitalize.
The Future of eClinical Trials Solution — Market Forecasts to 2015, Competitive Benchmarking and Case Studies
GBI Research, the leading business intelligence provider, has released its latest research new report, 'The Future of eClinical Trial Solutions — Market Forecasts to 2015, Competitive Benchmarking and Cast Studies report provides an analysis of various eClinical trial solutions that supports pharmaceutical companies to conduct clinical trials. The report provides a special emphasis on the advancement of new technologies and how it is helps pharmaceutical companies to cut down costs in clinical trials. The report initially touches upon areas where clinical trial solutions are widely utilized. The pain points and issues in each of the segments are discussed and solution overviews for these issues are provided. Various scenarios are provided to understand cost savings on adopting the solutions. Case studies are provided to all segments to understand real-time benefits of the solutions and services. The later part of the report comprises of market trends, market drivers and market challenges for vendors of eClinical trial solutions. More than 60 companies competitive benchmarking by solution offering is provided.
Adoption of eClinical Trial Solutions is Increasing Driven by Product Innovation aimed at Saving Cost in Clinical Trials
GBI Research analyzed the critical pain points that are responsible for the increase in timelines of the completion of clinical trials, the increase in costs to conduct a clinical trial, and the delay in time to the market. These pain points occur across all the various phases of clinical trials, particularly in Clinical Trial Planning, Data Capturing, Data Management, Reporting and Analysis. At present, pharmaceutical companies need to utilize advanced technologies that are available in the market. Apart from using electronic data capture, clinical data management solutions, clinical trial management solutions, eDiaries and interactive voice response systems, they should find innovative methods to integrate all these systems to optimize the process and derive the required cost saving benefits. Adaptive Clinical trials are aimed at striking a balance between the needed dose response information and the increased cost associated with it. The simulation of clinical trials allows pharmaceutical companies to compare and contrast the operating characteristics of the design options. Modeling, forecasting and tracking the clinical trial enrollment gives an opportunity for the team to identify the problems before they happen. This results in lowering the clinical trial cost and speeds up the time to regulatory submission. Those Companies wanting to reduce potential discrepancies in the process and save costs are utilizing these solutions.
Clinical Trial Supply Management System, a Source for Competitive Advantage & Cost cutting
Global Markets Direct finds that Clinical Trial supply management system is becoming as a source for competitive advantage that improvises manufacturing, packaging & the shipping processes. There has to be a supply chain strategy for transforming internal processes and combining it with supply chain best practices. For the initial forecasting, demand calculation functionality is important. The forecast has to be developed at each stages of the distribution point which is supplied to the investigators. This is important for the orders to happen in time to meet the demand requirements and also would support the just-in-time packaging and labeling. This will increase flexibility in the supply chain. The planning modules in the Clinical trial supply chain management system are also utilized to perform safety-lock planning to ensure availability levels. The minute the demand changes, the planning process also changes and helps to optimize the demand-supply scenario. This helps to cut down costs.
ePRO Solutions save considerable cost and time
Paper diary method is a lengthier process resulting in increase in cost and time. If Pharmaceutical Companies are adopting ePRO solutions, they save considerable cost and time.
Data Analysis and Standardization is Gaining Importance, Reduces the Time of Drug to the market.
Pharmaceutical companies are continually looking for better ways to reduce the time from the end-of-study to FDA submission. Accomplishing this requires addressing key issues that cause delays in collecting, verifying and auditing the accuracy of data and converting that data into the right format for statistical analysis. Disparate data combinations from multiple sources and systems can result in errors, discrepancies and a backlog of queries that require unplanned time and resources to resolve. As pharmaceutical companies and CROs manage increasing amounts of clinical information, ensuring data integrity and complying with industry standards become more important than ever. Minimizing the time from database lock to an analysis-ready data set is crucial in getting drugs to the FDA and the market faster. Spending on Phase III trials is Increasing and Verdicts on Increased Spending in eClinical Trial Solutions
The spending of phase 3 trials in the US was $18.5 billion compared to that of $12.9 billion in Europe in 2008. There is a substantial amount of spending allocated to eClinical trial solutions and services. This amount is expected to increase in the next few years. The increase of clinical trials in phase III and phase II is another important factor of consideration. On adopting the novel technologies, a Biopharmaceutical company can save millions in a large clinical trial.
Comprehending the latest evolving standards and following them is the biggest challenge. On utilizing eClinical trial solutions and services, a drug can reach the market much quicker than the traditional methods.
1.2 List of Figures
2 eClinical Trial Solutions Market: Market Overview
2.1 Introduction to eClinical Trial Solutions
2.2 Market Segmentation
2.2.1 Clinical Trial Planning
2.2.2 Clinical Data Capture
2.2.3 Clinical Data Management
2.2.4 Clinical Data Analysis and Reporting
2.2.5 Overview of eClinical Trial Solutions
3 eClinical Trial Solutions Market: Case Studies
4 eClinical Trial Solutions Market: Market Characterization
4.1 Market Size & Forecasts for eClinical Trial Solutions
4.1.1 Clinical Trial Management System Market
4.1.2 Electronic Data Capture Market
4.1.3 ePRO Market
4.1.4 IVRS Market
4.2 Market Drivers
4.2.1 Cutting Down Clinical Trial Cost is the Driving Motivation for the Adoption of eClinical Trial Solutions
4.2.2 Improved Data Standardization Increases Adoption of IT Solutions
4.2.3 Adaptive Clinical Trials are Preferred by Large Biopharmaceutical Companies
4.2.4 Increasing Phase III and Phase II Trials escalates eClinical Solution Adoption
4.2.5 'Expansion of Indication– of the existing drugs is a new market opportunity
4.3 Market Challenges
4.3.1 The need for improvisation of solution
4.4 Market Trends
4.4.1 Clinical Trial Spending is Increasing at a Faster Rate
4.4.2 R&D Spending is Highest in the US
4.4.3 Phase III Spending is the Highest in Europe and the US
4.4.4 Market Potential for eClinical Solutions by Phases (US & Europe) is Largely from Phase III
4.4.5 Electronic Data Capture will Foresee the Highest Investment for the Next Five years
4.5 Adoption Trends
4.6 Geographical Trend
4.6.1 Developing Nations have a strong potential for growth in the future.
5 eClinical Trial Solutions Market: Technology Trends
5.1 Business Models
5.1.2 Case Studies
5.2 CDISC Standards
5.2.6 Protocol standard
5.2.7 CDISC Sponsored studies save time and costs
5.2.8 Adoption of Various Standards
5.2.9 Cost Saving for a Single Study
5.2.10 Revenue Gained for a Single Product
5.2.11 Case Studies
6 eClinical Trial Solutions Market: Competetive Landscape
6.1 Competitive Benchmarking by Solution Offerings
6.2 eClinical Trial Solutions - Company Profiles
6.2.1 KIKA Medical
6.2.2 Omnicomm Systems
6.2.3 eResearch Technology
6.2.4 Prelude Dynamics
6.2.6 Phase Forward
6.2.7 Perceptive Informatics
7 eClinical Trial Solutions Market: Appendix
7.1 Market Definitions
7.2 Key Support Data
7.3 List of Abbreviations
7.4 Research Methodology
7.4.2 Secondary Research
7.4.3 Primary Research
7.4.4 Expert Panel Validation
7.5 Contact Us
Table 1: eClinical Trial Solutions Market, Global, Phase I-II Cost Saving Scenario by Adopting EDC , 2009
Table 2: eClinical Trial Solutions Market, Global, Data Management Set Up Cost in India, 2009
Table 3: eClinical Trial Solutions Market, Global, CDISC Sponsored Studies, 2009
Table 4: eClinical Trail Solutions Market, Global, Competitive Benchmarking by Solutions Offering, 2009
Figure 1: eClinical Trial Solutions Market, Global, Segmentation by Activities , 2009
Figure 2: eClinical Trial Solutions Market, Global, Supply Chain in Clinical Trials , 2009
Figure 3: eClinical Trial Solutions Market, Global, Paper CRF Method of Data Capturing , 2009
Figure 4: eClinical Trial Solutions Market, Global, Typical Clinical Trial Management System, 2009
Figure 5: eClinical Trial Solutions Market, Global, Electronic Data Capture through e-CRF, 2009
Figure 6: eClinical Trial Solutions Market, Global, EDC System- Cost Saving Scenario, 2009
Figure 7: eClinical Trial Solutions Market, Global, Data Quality Gap, 2009
Figure 8: eClinical Trial Solutions Market, Global, SaaS based EDC System, 2009
Figure 9: eClinical Trial Solutions Market, Global, Cost Saving Scenario of ePRO Solutions, 2009
Figure 10: eClinical Trial Solutions Market, Global, Case Study of ePRO Solutions, 2009
Figure 11: eClinical Trial Solutions Market, Global, Integration of IVR with other Systems, 2009
Figure 12: eClinical Trial Solutions Market, Global, Clinical Data Management Flow, 2009
Figure 13: eClinical Trial Solutions Market, Global, Clinical Trial Supply Management System, 2009
Figure 14: eClinical Trial Solutions Market, Global, RFID Technologies in Clinical Trials, 2009
Figure 15: eClinical Trial Solutions Market, Global, Cost Saving Scenario of a Predictive Modeling Solution, 2009
Figure 16: eClinical Trial Solutions Market, Global, EDC Cost Saving in Clinical Trials — Therapy Wise, 2009
Figure 17: eClinical Trial Solutions Market, Global, Clinical Trial Management System Market, 2009-2015
Figure 18: eClinical Trial Solutions Market, Global, Electronic Data Capture Market, 2009-2015
Figure 19: eClinical Trial Solutions Market, Global, ePRO Market, 2009-2015
Figure 20: eClinical Trial Solutions Market, Global, IVRS Market, 2009-2015
Figure 21: eClinical Trial Solutions Market, Global, Cutting Down Clinical Trial Cost is a High Priority Task for Pharmaceutical Companies- Impact Analysis, 2009
Figure 22: eClinical Trial Solutions Market, Global, Research and Development Spent Split by Phases — Impact Analysis
Figure 23: eClinical Trial Solutions Market, Global, Adaptive Clinical Trials are Preferred by large biopharmaceutical companies - Impact Analysis, 2009
Figure 24: eClinical Trial Solutions Market, Global, Increasing Phase III and phase II trials escalates eClinical Solution Adoption — Impact Analysis, 2009
Figure 25: eClinical Trial Solutions Market, Global, Expansion of indication of drugs — Impact Analysis, 2009
Figure 26: eClinical Trial Solutions Market, Global, Need for improvisation of solution — Impact Analysis, 2009
Figure 27: eClinical Trial Solutions Market, Global, Research and Development Spent Split by Phases — Impact Analysis, 2009
Figure 28: eClinical Trial Solutions Market, Global, Spending on Research and Development in US and Europe, 2009
Figure 29: eClinical Trial Solutions Market, Global, Value of Spending in R&D by Phases, 2009
Figure 30: eClinical Trial Solutions Market, Global, Market Potential for eClinical Solutions, 2009
Figure 31: Investment Trends in Future
Figure 32: eClinical Trial Solutions Market, Global, CTMS — Technology Adoption, 2009
Figure 33: eClinical Trial Solutions Market, Global, Investigator Portal — Technology Adoption, 2009
Figure 34: eClinical Trial Solutions Market, Global, System Integration — Technology Adoption, 2009
Figure 35: eClinical Trial Solutions Market, Global, ePRO Solutions — Technology Adoption, 2009
Figure 36: eClinical Trial Solutions Market, Global, IVRS Solutions — Technology Adoption, 2009
Figure 37: eClinical Trial Solutions Market, Global, Increase in Initiations of Clinical Trials in Developing Nations, 2009
Figure 38: eClinical Trial Solutions Market, Global, Factors Impacting Clinical Data Management Outsourcing, 2009
Figure 39: eClinical Trial Solutions Market, Global, End-to-End Services Offered by Large IT Vendors , 2009
Figure 40: eClinical Trial Solutions Market, Global, Supply Chain in Clinical Trials , 2009
Figure 41: eClinical Trial Solutions Market, Global, Adoption of CDISC Standards , 2009
Figure 42: eClinical Trial Solutions Market, Global, Cost Saving for a Single Study Using CDISC, 2009
Figure 43: eClinical Trial Solutions Market, Global, Revenue Gained for a Single Product Using CDISC , 2009
Figure 44: GBI Research Methodology
- Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management
- Telehealth and Telemedicine - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
- Global Healthcare Building Construction to 2015: Market Snapshot
- Healthcare Building Construction in Libya to 2015: Market Snapshot
- Healthcare Building Construction in Romania to 2015: Market Snapshot
- Healthcare Building Construction in Slovenia to 2015: Market Snapshot
- Home Improvement and Gardening Supplies Retailers in Venezuela
- Telemedicine Market in Brazil, Russia, India, China (BRIC)
- A strong case for telehealth in Europe
- Electronic health records: getting it right first time
- Healthcare IT: A Market Poised for Strong Growth in the Future
- Electronic health records in Western Europe – still a local affair?
- Global Mechanical Computer Aided Design (MCAD) Software Market 2008-2012
- National eHealth strategy progress in Australia
- 2009: A Year of mHealth Buzz, Hype (Analyst Opinion)
- 2010 Trends to Watch: Pharmaceutical Technology
- Global Cardiac Rhythm Management (CRM) Market 2008-2012
- Pharma Goes Cloud Gazing (Analyst Opinion)
- The Ever Changing Return on Investment of Electronic Health Records (Analyst Opinion)
- Meaningful Use of EHRs: The Good, the Bad and the Ugly (Analyst Insight)
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Hinweise: **The report can be shared by users within one office (one geographical location) ***Across Geographical locations (by the purchasing company only)